Core Insights - Meridian Growth Fund's third-quarter 2025 performance was negatively impacted by sector positioning and strict investment discipline, resulting in a return of -1.78% compared to the Russell 2500 Growth Index's 10.73% return [1] Company Overview: Align Technology, Inc. (NASDAQ:ALGN) - Align Technology, Inc. is a leader in dental technology, known for its Invisalign clear aligners and iTero intraoral scanners [3] - The stock experienced a one-month return of 6.25% but has lost 37.14% over the past 52 weeks, closing at $147.19 with a market capitalization of $10.669 billion on November 28, 2025 [2] Financial Performance - In Q3 2025, Align Technology reported revenue of $995.7 million, reflecting a 1.7% decline from the previous quarter but a 1.8% increase year-over-year [4] Market Dynamics - The company faced challenges with demand rebound expectations not materializing, particularly in the teen segment where revenue growth slowed to 3% [3] - Market share gains reversed due to a weaker macroeconomic environment affecting discretionary dental procedures and a shift towards lower-cost alternatives [3] Investment Sentiment - Align Technology was held by 48 hedge fund portfolios at the end of Q3 2025, a decrease from 54 in the previous quarter, indicating a decline in popularity among hedge funds [4] - Despite its potential, the company is viewed as less favorable compared to certain AI stocks that are perceived to offer greater upside potential and lower downside risk [4]

A month has gone by since the last earnings report for Align Technology (ALGN) . Shares have added about 6.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Align Technology due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the latest earnings report in order to get a better handle on the important catalysts.ALGN Q3 Earnings and Revenue Beat, Margins Cras ...

Core Insights - Align Technology, Inc. has received top-tier recognition in the 2025 All-America Executive Team rankings published by Extel Insights, highlighting its leadership in the medical device sector [1] Company Overview - Align Technology is a leading global medical device company that specializes in designing, manufacturing, and selling the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry [1]

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.It also includes access to the Zacks Style Scores. What are the Zacks Style Scores? Developed alongside ...

MANILA, Philippines--(BUSINESS WIRE)--Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTeroâ"¢ intraoral scanners, and exocadâ"¢ CAD/CAM software for digital orthodontics and restorative dentistry, today announced commercial availability in the Philippines of the Invisalign System with mandibular advancement featuring occlusal blocks designed specifically to address Class II skeletal and d. ...

Core Insights - Align Technology, Inc. has a market capitalization of $10.2 billion and is recognized for its Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners, providing advanced orthodontic and restorative digital solutions globally [1] Stock Performance - Over the past 52 weeks, Align Technology's shares have decreased by 37.5%, underperforming the S&P 500 Index, which gained 11% during the same period [2] - Year-to-date, the stock has dropped 31.6%, while the S&P 500 has risen by 12.3% [2] Recent Financial Results - Following the Q3 2025 results released on October 29, shares surged by 4.9%, with adjusted EPS at $2.61 and revenue reaching $995.7 million, surpassing consensus estimates [4] - Align Technology raised its Q4 revenue forecast to between $1.03 billion and $1.05 billion, anticipating mid-single-digit growth in Clear Aligner volumes [4] Earnings Expectations - For the fiscal year ending December 2025, analysts project a 16.7% year-over-year increase in EPS to $8.18 [5] - The company's earnings surprise history is mixed, with two beats and two misses in the last four quarters [5] Analyst Ratings - Among 14 analysts covering Align Technology, the consensus rating is a "Moderate Buy," consisting of eight "Strong Buy" ratings, five "Holds," and one "Moderate Sell" [5] - This rating configuration is slightly less bullish than three months ago, which had nine "Strong Buy" ratings [6] Price Targets - Evercore ISI raised its price target on Align Technology to $170, maintaining an "Outperform" rating [7] - The mean price target of $173.25 indicates a potential upside of 21.5% from the current price, while the highest target of $205 suggests a 43.8% upside [7]

Core Viewpoint - The company expresses confidence in its strategic position and technological capabilities in the dental industry, emphasizing its leadership in orthodontic solutions and manufacturing efficiency [1][2]. Group 1: Company Strengths - The company has nearly 30 years of experience in the industry, positioning itself as the leader in moving teeth effectively [1]. - It has a strong manufacturing presence in key locations including China, Poland, and Mexico, ensuring comprehensive coverage of its operational needs [1]. - The breadth of technology has improved significantly, allowing the company to handle 100% of current orthodontic cases [1]. Group 2: Competitive Advantages - The company highlights its unique position in the market, stating that no competitor can match its capabilities in orthodontic treatment and technology [2]. - Advancements in 3D printing and touchless ClinCheck technology enable faster and more predictable case management [2].

Align Technology Conference Call Summary Company Overview - **Company**: Align Technology (NasdaqGS:ALGN) - **Industry**: Medical Supplies and Devices, specifically in the clear aligner market Key Points and Arguments Strategic Positioning - Align Technology has a strong strategic position in the clear aligner market, leveraging nearly 30 years of experience and superior technology for moving teeth [2][3] - The company has manufacturing plants in China, Poland, and Mexico, allowing for a well-distributed operational footprint [2] Market Performance - The U.S. market showed improved year-over-year growth, but challenges remain, particularly in the retail segment [4] - The Direct Sales Organization (DSO) business is growing significantly, with some areas exceeding 20% growth, contrasting with a sluggish retail business [4][6] Sales and Marketing Strategies - Align is focusing on solidifying and growing its DSO base and utilizing financing tools to enhance retail growth [4] - Active conversion strategies are being employed to drive patient traffic to practices, including discounts and financing options [5][6] Product Offerings and Innovations - Align is rolling out products with lower upfront costs, which are resonating well with both DSOs and retail accounts [12][13] - The company is enhancing its product portfolio with innovations like mandibular advancement and improved 3D printing technologies [16][36] Financial Performance and Projections - Align expects to achieve at least a 100 basis point improvement in operating margins in 2026, driven by better product gross margins and operational efficiencies [30][31] - The company anticipates continued growth in Europe, Asia, and Latin America, with a focus on addressing the latent retail market in North America [16][17] Capital Allocation - Align is prioritizing cash generation to drive business growth, with a capital expenditure of approximately $100 million for the year, primarily for existing facilities and DirectFab initiatives [37][38] - The company is actively engaging in share buybacks, with a current program of $200 million expected to be completed by the end of January [38] Technology and Equipment Updates - Align is phasing out support for older iTero Element systems by January 1, 2026, and is promoting upgrades to newer models [18][20] - The company is also launching new products like the Lumina scanner with restorative capabilities, which has received positive feedback [20] Challenges and Market Dynamics - The dental market is fragmented, and Align is adapting its strategies to meet diverse practitioner needs [29] - There is a significant price elasticity in the market, allowing for flexible purchasing options that cater to different customer segments [13] Future Outlook - Align is optimistic about the rollout of new products and technologies, which are expected to enhance operational efficiency and customer satisfaction [36] - The company is committed to maintaining its focus on core competencies in orthodontics and will not pursue diversification into unrelated acquisitions [38] This summary encapsulates the key insights from the Align Technology conference call, highlighting the company's strategic positioning, market performance, product innovations, financial outlook, and future growth strategies.

Group 1 - The Magnificent Seven, a group of tech-focused firms, dominate the S&P 500, accounting for one-third of its total market capitalization [2] - The Roundhill Magnificent Seven ETF (BATS: MAGS) has returned nearly 20% year-to-date, outperforming the broader market despite early 2025 volatility [2] - Investors may overlook promising opportunities in tech-adjacent companies with strong fundamentals, such as Align Technology, Marvell Technology, and EPAM Systems [3] Group 2 - Align Technology, known for its Invisalign system, leverages AI to enhance efficiency in the orthodontic market, positioning itself as a tech-focused option in the medical device sector [4] - In Q3, Align Technology reported a revenue increase of approximately 2% year-over-year, reaching nearly $1 billion, with earnings per share exceeding analyst expectations by 23 cents [5] - The growth of Align Technology is driven by increased adoption rates among teens and children, aided by AI in treatment planning [5]

Core Insights - The company reported strong growth in Clear Aligner volumes across EMEA, APAC, and Latin America during the third quarter [1] Growth Drivers - The growth in Clear Aligner volumes is attributed to multiple factors including the signing of new doctors, increased utilization rates, and the launch of new products [1] - The company is seeking to provide more detailed insights into individual market performance, particularly in regions where obtaining key performance indicators (KPIs) is challenging [1]